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Summary
To understand how CD8 expression is regulated dur-
ing the transition process from CD4+8+ (CD4 and CD8
double positive, DP) to CD4−8+ (CD8 single positive,
CD8SP) cells in the thymus, the involvement of Runx
proteins in the alteration of chromatin configuration
was investigated. Using the chromatin immunoprecip-
itation assay, we first demonstrated that Runx pro-
teins bind to the stage-specific CD8 enhancer, as well
as the CD4 silencer, in CD8SP thymocytes. Among
Runx family members, Runx3 expression was initi-
ated in DP thymocytes receiving a positive selection
signal and increased in concert with differentiation to
the CD8SP stage. Furthermore, reactivation of the
CD8 gene, as well as CD4 silencing, was suppressed
in positively selected thymocytes of Runx dominant-
negative transgenic mice. These results suggest that
Runx proteins, especially Runx3, are involved in lin-
eage specification of CD8 T cells and provide impor-
tant information for understanding the mechanism for
the mutually exclusive expression of coreceptors in
mature thymocytes.
Introduction
CD4+CD8+ double positive (DP) thymocytes are com-
mon precursors for CD4+CD8− (CD4SP) and CD4−CD8+
(CD8SP) cells. DP thymocytes expressing major histo-
compatibility complex (MHC) class I-specific T cell re-
ceptor (TCR) differentiate into CD8SP T cells, whereas
those expressing MHC class II-specific TCR differenti-
ate into CD4SP T cells. Many studies have been per-
formed to clarify the molecular basis for the cell fate
specification of immature T cells mainly by two types
of approach, the “top-down” approach and the “bot-
toms-up” approach (Hedrick, 2002).*Correspondence: sonoko@is.icc.u-tokai.ac.jpUsing “top-down” approaches, TCR and coreceptor
signaling for cell fate decision and selection have been
intensively studied. It was recently indicated that strong
or sustained TCR signals can induce DP cells to de-
velop into CD4SP cells, whereas weak or transient TCR
signals can induce development of CD8SP cells (Brug-
nera et al., 2000; Hernández-Hoyos et al., 2000; Ohoka
et al., 1997; Sharp et al., 1997; Schmedt and Tarakhov-
sky, 2001; Yasutomo et al., 2000). The asymmetric
downregulation of coreceptors has also been pro-
posed; positively selected DP cells often transiently de-
crease CD8 expression to become CD4+8lo cells re-
gardless of which MHC class is involved with the
initiating TCR signal, and thereafter they develop into
either CD4SP or CD8SP cells. According to this pro-
posal, both CD8 reexpression and CD4 repression must
occur in developing CD8SP lineage cells (Germain,
2002; Lundberg et al., 1995 Suzuki et al., 1995). How-
ever, little is known about the molecular basis for
these events.
From “bottoms-up” approaches, which investigate
the developmental regulation of lineage-specific genes
such as CD4 and CD8, several regulatory regions in
CD4 and CD8 genes have been identified (Ellmeier et
al., 1999; Hostert et al., 1997a, 1997b; Sawada et al.,
1994; Siu et al., 1994). For the CD4 gene locus, at least
two enhancers and an intronic silencer are described in
addition to a promoter, and, through the silencer, Runx
proteins are reported to repress CD4 expression in
CD4−CD8− (DN) and CD8SP cells (Taniuchi et al., 2002a,
2002b). In the CD8 gene locus, at least five enhancer
regions have been mapped (Hedrick, 2002; Kioussis
and Ellmeier, 2002). Using Tg mice of the reporter gene
under the control of CD8 enhancers such as E8I and
E8III, it was reported that these enhancer regions func-
tion for CD8 expression in a stage-specific manner. In
E8I-driven reporter gene-Tg mice, the reporter gene is
expressed in CD8SP cells (Ellmeier et al., 1997; Hostert
et al., 1997b, 1998), but in E8III-driven reporter gene-Tg
mice, reporter gene expression is exclusively detected
in DP cells (Ellmeier et al., 1998). These findings enabled
us to assume that certain trans-acting factors are in-
duced or function in a stage-specific manner for activa-
ting the CD8 gene, and that they consequently play im-
portant roles for generating CD8SP cells.
Several candidate molecules are known to bind to
the CD8 gene regulatory elements and to control its
expression. GATA3, SATB1, and CDP are reported to
bind to the CD8 enhancer region in CD8-expressing cell
lines (Banan et al., 1997; Landry et al., 1993), but their
in vivo contribution to CD8 T cell development has yet
to be elucidated. Among such transcription factors,
Ikaros is reported to bind to the CD8 enhancer regions
E8I and E8V in vivo, and it directs the expression of E8I-
and E8V-driven reporter genes in CD8SP thymocytes
(Harker et al., 2002). Since Ikaros is known to form a
complex with chromatin-remodeling molecules and to
affect nuclear compartmentalization (Avitahl et al.,
1999; Brown et al., 1997), it is assumed that CD8 ex-
pression can be regulated by alteration of chromatin
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atrans-acting factors, including Ikaros. This assumption
is consistent with another observation, in which muta- (
rtions in chromatin-remodeling factor SWI/SNF-like com-
plex resulted in CD8 misregulation of developing thy- l
Cmocytes (Chi et al., 2002).
The Runx/AML family is a DNA binding protein known 2
Cto comprise critical regulators for haematopoiesis, os-
teogenesis, and neurogenesis (see review, Ito, 2004). c
vRunx family proteins possess the Runt domain that has
the ability to bind to its β subunit and the consensus w
bsequence of DNA and to control target gene expression
positively and negatively in a context-dependent man- a
sner. Runx is suggested to be involved in chromatin re-
modeling through binding to chromatin-modifying t
bmolecules such as CBP, p300, mSin3A, Groucho/TLE,
SUV39H1, and so on (Chakraborty et al., 2003; Down- t
cing, 2003). Furthermore, Runx proteins are directed to
subnuclear foci via their nuclear matrix targeting signal e
t(NMTS), suggesting that Runx controls gene expres-
sion by recruiting the target sequence to some sub- b
Cnuclear compartments containing various gene regula-
tory factors (Telfer et al., 2004; Zaidi et al., 2002). In this C
study, we show that Runx binds to CD8 gene enhancer
regions, as well as to the CD4 silencer region, and that i
camong the three family members (Runx1, Runx2,
Runx3), Runx3 protein is selectively expressed in the w
iCD8SP lineage and controls CD8 expression positively
in the lineage. These findings have given rise to the C
mhypothesis that Runx3 is a master regulator for CD8 T
cell generation and provides important information for f
eunderstanding the mechanism for the mutually exclu-
sive expression of coreceptors in CD4SP/CD8SP cells. s
a
gResults
t
FRunx Protein Binds to CD8 Enhancers as Well
Eas the CD4 Silencer in CD8SP Thymocytes
eDuring the transition process from DP to CD8SP in the
2thymus, the silencer region of the CD4 gene has been
tshown to play a pivotal role in CD4 downregulation but
shas not been shown to execute for the maintenance of
the silent status (Leung et al., 2001; Zou et al., 2001).
tThis gene silencing is under regulation of Runx proteins
(such as Runx3 and Runx1 (Taniuchi et al., 2002a). How-
wever, it is still unclear whether Runx proteins are in-
ivolved in CD8 gene expression. To address this issue,
ewe investigated the binding status of Runx protein and
ethe histone acetylation level in CD4 and CD8 genes by
mchromatin immunoprecipitation (ChIP) assay. For that,
bthe chromatin fractions prepared from DN, DP, CD4SP,
Cand CD8SP thymocyte subpopulations of adult mice
2were subjected to immunoprecipitation with antibodies
Cagainst pan-Runx and acetylated histone 3 (Ac-H3),
sand the precipitated DNAs were applied to PCR.
DFirst, we examined whether Runx proteins bind sub-
rstantially to the CD4 silencer region. As shown in Figure
s1A, the fragment containing the CD4 intronic silencer
Cregion showed greater amplification in anti-pan-Runx-
wprecipitated DNA of CD8SP cells than in the three other
csubpopulations (index 46 in CD8SP versus 9.6, 12, and
g6.7 in DN, DP, and CD4SP cells, respectively). However,
the enhancer sequence of TCR b chain (Eb), which is rnown as a target of Runx1 (Wotton et al., 1994), was
mplified equally between CD8SP and CD4SP cells
Figure 1B). These results are consistent with the recent
eports that the Runx binding sites within the CD4 si-
encer region and Runx proteins are required for proper
D4 repression in CD8SP thymocytes (Taniuchi et al.,
002a, 2002b). In anti-Ac-H3-precipitated DNA, the
D4 silencer fragment was less amplified in CD8SP
ells than in CD4SP and DP cells (index 39 in CD8SP
ersus 96 and 77 in CD4SP and DP cells, respectively),
hich was inversely correlated with the prominent
inding of Runx to the CD4 silencer region as described
bove. This decreased histone acetylation of the CD4
ilencer region is in accord with the repressive state of
he CD4 gene in CD8SP cells. In fact, Runx is known to
ind to mSin3A and Groucho/TLE, through which his-
one deacethyltransferase (HDAC) complex may be re-
ruited to the CD4 silencer region in CD8SP cells. How-
ver, the binding of Runx was not evident in DN cells,
hough the decreased acetylation was observed. It may
e assumed that the contribution of Runx proteins to
D4 silencing is less prominent in DN cells than in
D8SP cells.
In the CD8 gene locus, several DNaseI hypersensitiv-
ty sites (HS sites) (arrows in Figure 2, top) form three
lusters that contain at least five regions associated
ith the enhancer activity (E8I, E8II, E8III, E8IV, and E8V
n Figure 2). These enhancer regions are involved in
D8 expression in the different developing stages (Ell-
eier et al., 1997, 1998; Hostert et al., 1997b, 1998). We
ound numerous potential Runx binding sites in these
nhancer regions by computer analysis (data not
hown). We then analyzed Runx binding and histone
cetylation status in these enhancer regions of the CD8
ene locus. Sixteen sets of PCR primers were designed
o amplify each region of the CD8 locus (sites a–p in
igure 2, middle). The binding of Runx proteins to E8I,
8II, and E8V was almost exclusively detected in CD8-
xpressing cells such as DP and CD8SP cells (Figure
, closed bars at sites d, e, h, i, m, n, and o), whereas
he binding to E8IV was detected equally in the four
ubpopulations (Figure 2, site a).
It is noteworthy that Runx binding to E8I was ex-
remely elevated in CD8SP cells, but not in DP cells
sites h and i). This preferential binding is consistent
ith previous studies of a reporter transgenic assay,
n which the E8I-driven reporter gene was selectively
xpressed in CD8SP cells, but not in DP cells (Ellmeier
t al., 1997; Hostert et al., 1997b). In addition, the
ultiple binding to CD8 enhancer regions of Runx may
e consistent with the previous reports showing that
D8 enhancers have redundant function (Ellmeier et al.,
002). Histone acetylation was enhanced in DP and
D8SP cells at several sites (Figure 2, open bars at
ites c, d, g, i, j, k, n, o, and p), in comparison with
N and CD4SP cells. Among these sites, the cluster III
egion (sites g, h, i, j, and k), which contains E8I,
howed greatly enhanced acetylation, especially in
D8SP cells. Since Runx is known to be associated
ith histone acetyltransferase (HAT), as well as HDAC
omplex, Runx may function as an activator of the CD8
ene by the recruitment of HAT to the E8I-containing
egion in CD8SP cells. It is to be clarified how Runx
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319Figure 1. Runx Proteins Associate at the CD4
Intronic Silencer Region in CD4-8+ Single
Positive Thymocytes.
(A and B) PCR analysis of the chromatin-
immunoprecipitated DNAs of CD4−8+ (DN),
CD4+8+ (DP), CD4+8− (4SP), and CD4−8+
(8SP) thymocytes by using normal rabbit IgG
(Rab), anti-pan-Runx (Runx), and anti-AcH3
(Ac-H3) antibodies. Amplified DNAs were hy-
bridized with internal oligo-DNA probes ([A],
CD4 intronic silencer; [B], TCR-b enhancer
region). Densitometric quantification for PCR
products of anti-pan-Runx (closed bars) or
anti-acetylated histone H3 (open bars) im-
munoprecipitants relative to the input is il-
lustrated. The values were calculated as fol-
lows: ([signal intensities of anti-pan-Runx or
anti-AcH3 precipitates] − [Rabbit IgG precip-
itates])/(input DNA).sion level of Runx family proteins in thymocyte subpop- antibody against the entire Runx family (Runx1, Runx2,
Figure 2. Mapping of Runx Protein Associations at the CD8-ab Locus in CD8SP Thymocytes
(Top) The location and direction of CD8-a and CD8-b genes are shown. The three clusters (labeled CII, CIII, and CIV) of DNaseI hypersensitive
sites (HS sites, arrows) and the previously reported enhancer regions (E8I–E8V, open boxes) are indicated. (Middle) PCR and subsequent
Southern hybridization analysis of chromatin-immunoprecipitated DNA from CD4SP and CD8SP thymocytes at 16 sites spanning CD8 en-
hancer regions are shown. (Bottom) Densitometric quantification of anti-pan-Runx (closed bars) or anti-acetylated histone H3 (open bars)
relative to the input fraction is illustrated. The values were calculated as in Figure 1. The relative signal intensities of anti-pan-Runx-immuno-
precipitated fractions are expressed in numerical values.acts as an activator of CD8 and as a repressor of CD4
in the same cell.
Runx3 Protein Is Preferentially Expressed
in CD8SP Cells
Since the binding pattern of Runx proteins was altered
in each development stage, we examined the expres-ulations by Western blot analysis (Figure 3A). The doublet
band, 56/58 kDa, was detected by Runx1-specific anti-
body in four subpopulations, DN, DP, CD4SP, and
CD8SP thymocytes, of adult mice (Figure 3A, lanes
1–4). Among the four subpopulations, Runx1 expres-
sion was most prominent in DN cells and was almost
equal in the other three subpopulations. When using
Immunity
320Figure 3. Runx Protein Expression in Thymocyte Subpopulations
(A) Runx3 protein is selectively expressed in CD8SP thymocytes. Equal numbers of CD4−8− (DN), CD4+8+ (DP), CD4+8− (4SP), and CD4−8+
(8SP) thymocytes were processed for immunoblot analysis by using the antibodies for Runx1 (left) and pan-Runx (middle). To check the
specificity of the antibody against pan-Runx, an excess amount of antigen peptide was included in the immunoreactions in parallel (right).
(B) The expression level of Runx3 is increased along the course of differentiation from DP to CD8SP stages. DP thymocytes without CD69
expression were prepared from a MHC class I and II-double deficient mouse (frc.I). DP and CD4+8lo cells expressing CD69 were prepared
from a MHC class II-deficient mouse (frc.II). CD8SP cells, expressing and not expressing CD69, were prepared from a MHC class II-deficient
mouse (frc.III and frc.IV, respectively). The protein extracts of the four fractions were processed for immunoblot analysis with anti-pan-Runx
antibody. The relative intensities of the upper band of Runx3 are indicated (closed bars).
(C) Runx3 expression is transiently increased, and decreased thereafter, in the differentiation pathway from DP to CD4SP stages. DP thymo-
cytes without CD69 expression were prepared from a MHC class I and II-double deficient mouse (frc.I). CD4+8lo cells expressing CD69, and
CD4SP cells with and without CD69 expression, were prepared from a MHC class I-deficient mouse (frc.II, frc.III, and frc.IV, respectively). The
protein extracts of the four fractions were processed for immunoblot analysis with anti-pan-Runx antibody. The relative intensities of the
upper band of Runx3 are indicated (closed bars).
(D) The binding of Runx proteins to the CD4 silencer and CD8 enhancer is mainly attributed to Runx3. Immunoprecipitated DNA with anti-
pan-Runx (closed bars) and with anti-Runx1 (open bars) of thymocyte subpopulations was analyzed by specific PCR as in Figures 1 and 2.
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321and Runx3), another distinct doublet band, 50/48 kDa,
was found only in CD8SP thymocytes, in addition to
the 56/58 kDa band (lanes 5–8). The specificity of the
antibody was confirmed by a neutralization experiment
(same as that in Hayashi et al., 2000), in which the
Runx-derived antigen peptide inhibited the binding of
antibody to both doublets (lanes 9–12). Judging by the
molecular weight, this 50/48 kDa doublet band is
thought to be Runx3, but not Runx1 or Runx2.
Gradual Expression of Runx3 in Developing Pathway
from Postselected DP to CD8SP Cells
DP cells selected via TCR-mediated signaling are re-
ported to show the CD4+8lo phenotype transiently be-
fore becoming authentic CD4/8SP cells. Our finding of
Runx3 expression in CD8SP cells leads to the predic-
tion that Runx3 may possibly be involved in the reacti-
vation of CD8 when CD4+8lo cells transit to the CD8SP
stage through the stage-specific enhancer E8I. To ad-
dress this, Runx3 expression was examined in each de-
veloping thymocyte from DP to CD8SP (Figure 3B) or
to CD4SP (Figure 3C) cells through the CD4+8lo cell
stage. For this, such developing thymocytes from the
DP to SP stages were fractionated into CD69-positive
and -negative cells. CD69-positive cells were further
fractionated into fraction II (frc.II), containing DP and
CD4+8lo cells, and fraction III (frc.III), composed of CD8
or CD4SP cells. From CD69-negative cells, mature
CD8SP and CD4SP cells were isolated as fraction IV
(frc.IV). These three fractions (frc.II, III, IV) were ob-
tained from MHC class II knockout (KO) mice (Figure
3B) and class I KO mice (Figure 3C). As preselected DP
cells, CD69-negative DP cells were obtained from MHC
class I and II double KO mice (frc.I). Runx3 was ex-
pressed to some extent in frc.II and was greatly ex-
pressed in frc.III and frc.IV in the CD8SP cell pathway,
but Runx3 expression was barely increased in the
CD4SP pathway (Figure 3C). These results indicated
that Runx3 protein begins to express at the early post-
selected stage and then greatly increases its expres-
sion toward the CD8SP stage, but not to CD4SP cells.
Since Runx1 expression did not change significantly
during the same developing process, Runx protein that
binds prominently to the CD8SP stage-specific en-
hancer E8I in CD8SP cells is suggested to be mainly
Runx3. Indeed, the ChIP assay with anti-Runx1 anti-
body did not show preferential binding to either E8I or
CD4 silencer regions in CD8SP cells compared to
CD4SP cells (Figure 3D).
Two-Step RTOC for Analyzing the Transition Process
in Which Preselected DP Thymocytes Are Induced
to Become CD8SP Cells via the CD4+8lo Stage
When transient CD4+8lo cells develop into CD8SP cells
in the context of class I restriction, CD8 expression
must be upregulated. However, little is known about the
molecular mechanism regulating CD8 expression during
the developing stage. To address this issue, we gener-
ated an in vitro experimental system, a modified reaggre-
gated thymus organ culture (RTOC), in which preselected
DP thymocytes are induced to become CD4−8+ SP cells
through the CD4+8lo stage. Preselected DP thymocytes
were obtained from TCR-Tg mice that had been back-crossed with RAG2−/− mice with nonselecting MHC
(Sato et al., 1994). In the double mutant mice desig-
nated as TCR-Neut mice, none of the thymocytes re-
ceived positive selection signaling to differentiate to the
SP stages due to the lack of selecting MHC, I-Ad. When
the preselected DP thymocytes of the double mutant
mice were reaggregated with BALB/c-derived thymic
stromal/epithelial cells (TEC), CD4+8loCD69+ cells ap-
peared on day 1, and the majority became CD4SP cells
on day 2 (Figure 4A, middle, and data not shown).
Interestingly, however, these 1-day cultured CD4+8lo-
CD69+ cells reexpressed CD8 with gradual CD4 silenc-
ing to become CD8high SP cells when they were trans-
ferred to a secondary RTOC with C57BL/6-derived TEC
with nonselecting MHC (Figure 4A, bottom). It is nota-
ble that the same nonselected DP thymocytes stayed
in the DP stage when they were in RTOC with C57BL/6
TEC from day 0 (Figure 4A, top). CD8SP cells induced
in the two-step RTOC showed mature phenotypes; they
expressed increased levels of TCR and perforin and a
decreased level of heat-stable antigen (HSA, CD24)
compared to DP thymocytes of both preculture TCR-
Neut and normal mice (Figures 4B and 4C). These re-
sults are consistent with the previous observations that
a transient or sustained TCR signal induces the devel-
opment of CD8SP or CD4SP cells from the DP stage,
respectively. Therefore, this two-step RTOC in combi-
nation with TCR-Neut DP thymocytes was considered
to be a good model for studying the molecular mecha-
nism during the developmental process from DP to
CD8SP thymocytes through the CD4+8lo stage.
Runx Is Involved in CD8 Reexpression and CD4
Silencing in the Process from Intermediate
CD4+8lo to CD8SP Cells
The Runt domain, which is well conserved among the
Runx family members, binds to the DNA consensus se-
quence and the β subunit, PEBP2β, more strongly than
the full-length Runx proteins. Consequently, Runt acts
as a dominant-negative (dn) form of each Runx protein.
We have produced a mutant mouse expressing Runt
domain in a T cell-specific manner under the control of
the CD2 promoter (Hayashi et al., 2000). Runx dn-Tg
mice were backcrossed with TCR-Neut mice and were
designated as Runx dn-TCR-Neut mice in this study. As
previously reported, the protein amount of endogenous
Runx and the DNA binding activity were markedly re-
duced in Runx dn-TCR-Neut thymocytes. The propor-
tions of DP and DN thymocytes were almost the same
between control and Runx dn-TCR-Neut mice (Sato et
al., 2003) (Figure S2; see the Supplemental Data avail-
able with this article online).
In order to investigate whether Runx protein is essen-
tially involved in CD8 reexpression in the development
pathway from postselected DP thymocytes, DP thymo-
cytes of Runx dn-TCR-Neut mice were applied to the
two-step RTOC system described above (Figure 5A). In
the first-step RTOC, in which the DP cells of control
and Runx dn-TCR-Neut mice were reaggregated with
BALB/c TEC, CD8 expression was equally decreased,
and cells became “CD4+8lo” cells in both cultures at
day 1. However, when these 1-day cultured thymocytes
were transferred to the second culture of RTOC with
Immunity
322Figure 4. One- and Two-Step Reaggregated Thymus Culture System with RAG-2-Deficient TCR-Tg Mouse Thymocytes
(A) (Top and middle) One-step RTOC. Isolated CD4+8+-double positive (DP) thymocytes of a RAG-2-deficient, I-Ad-restricted, OVA323–339-
specific TCR-transgenic mouse that had been backcrossed with C57BL/6 (designated as TCR-Neut mouse) were reaggregated and cultured
with thymic epithelial cells (TEC) from a C57BL/6 (top) or BALB/c fetus (middle). In the absence of selecting MHC, I-Ad, almost all DP cells
remained to express both CD4 and CD8 after the culture with C57BL/6 TEC for 2 days. In the presence of I-Ad, CD8 expression was decreased
at day 1, and most cells showed the CD4SP phenotype by day 2 in the culture with BALB/c TEC. (Bottom) Two-step RTOC. Isolated DP
thymocytes of a TCR-Neut mouse were reaggregated and cultured with BALB/c TEC. After 1 day, the expression of CD8 was slightly de-
creased (“Day 1” in middle). Then, the collected “CD4+8lo” cells were reaggregated again for another 4 days with C57BL/6. Most thymocytes
came to show the CD8SP phenotype.
(B) CD8SP cells induced in the two-step RTOC expressed TCR-β at a high level and heat-stable antigen (HSA, CD24) at a low level (bottom).
These expression levels are similar to those of normal mature CD8SP thymocytes (third row). DP thymocytes of TCR-Neut mice (top) and
most of the normal DP thymocytes (second row) expressed TCR at a low level and HSA at a high level.
(C) After the two-step RTOC, cells expressed perforin. Preculture DP thymocytes (left) and postculture cells (right) were collected and analyzed
by semiquantitative RT-PCR for their expression of perforin (top) and GAPDH as a control (bottom).
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323Figure 5. Runx Is Involved in the Differentiation from “Intermediate CD4+8lo” Cells to CD8SP Cells
(A) DP thymocytes of control- and Runx-dominant negative (dn)-TCR-Neut mice were subjected to the “two-step RTOC” system. After 1-day
of RTOC with BALB/c TEC, collected thymocytes were reaggregated and cultured again with B6 TEC for 4 additional days. In a Runx dn-
TCR-Neut mouse, DP and CD8SP cells were decreased.
(B) The recovered cell number of CD4SP, DP, and CD8SP cells (open bars, control TCR-Neut; closed bars, Runx dn-TCR-Neut). Three indepen-
dent experiments showed similar results. Typical data are illustrated.
(C) After 1-day of RTOC with BALB/c TEC, CD8-negative cells were sorted (Day 1), and were then reaggregated and cultured with C57BL/6
TEC. In Runx dn-TCR-Neut, reexpression of CD8 and downregulation of CD4 were impaired.C57BL/6 TEC, the proportion of CD8SP cells in Runx
dn-TCR-Neut mice was much lower in comparison with
that of control-TCR-Neut mice (20.0% versus 72.6%).
Conversely, the CD4SP cell proportion was high (49.2%
versus 2.7%). As the decreased cell number of CD8SP
cells was accompanied by a reciprocal increase of
CD4SP cells (Figure 5B), the proportional change of
CD4SP and CD8SP cells in Runx dn-TCR-Neut mice
was not due to the selected death or proliferation of a
certain subpopulation, but rather to the decrease of
CD8 expression and CD4 silencing. This means, there-
fore, that CD8 reexpression and CD4 silencing are in-
hibited in Runx dn-TCR-Neut mice. To confirm the ef-
fect of Runx protein on CD8 reexpression, thymocytes
expressing low CD8 were isolated after the first-step
RTOC (more than 98% purity), and then were applied
to the second-step RTOC (Figure 5C). In Runx dn-TCR-
Neut cells, highly CD8-positive cells including DP and
CD8SP cells, comprised less than 50%, whereas they
comprised more than 90% in control TCR-Neut mice.
Next, the effect of Runx3 overexpression was exam-
ined by using Runx3-Tg mice. Thymus of a Runx3-Tg
mouse that had been backcrossed with a TCR-Neut
mouse contained DP and CD8SP cells (Figure 6 lower,
day 0, and Figure S2). Since both DP and CD8SP cells
in the mouse expressed TCR at a low level (Figure 6
bottom, day 0), it is suggested that Runx3 overexpres-
sion resulted in the variegated repression of CD4in nonselected DP thymocytes. On the other hand,
Runx3-overexpressing TCR-Tg mice in selecting MHC
contained many TCR-highly positive CD8SP cells
(Kohu et al., 2005) (Figure S2, and data not shown). Iso-
lated DP cells of control- and Runx3-overexpressing
TCR-Neut mice were cultured with BALB/c TEC. As de-
scribed above, the continuous culture with BALB/c TEC
for 2 days delivers a sustained signal and induces CD8
downregulation in the control TCR-Neut mouse (Figure
6, upper, days 1 and 2). Surprisingly, CD8 downregula-
tion was not observed in Runx3-overexpressing TCR-
Neut mice, and most cells instead showed CD4 down-
regulation to become CD8SP cells on day 2 (Figure 6
lower, days 1 and 2). Moreover, these CD8SP cells
showed increased TCR expression compared to pre-
culture DP cells, the same as CD4SP cells appearing in
the control culture, suggesting that they were induced
to mature by TCR-mediated signal. If Runx3 executed
only CD4 suppression via the CD4 silencer, postse-
lected cells would be CD4lowCD8low in Runx3-Tg
mice. Altogether, it is indicated that Runx3 possesses
the potential to activate CD8, as well as to repress CD4
in the postpositive selection stages.
Discussion
In this study, we first demonstrated that transcription
factor Runx proteins bind to the CD8 enhancer regions
Immunity
324Figure 6. Runx3 Overexpression Inhibits CD8
Downregulation in a CD4SP Cell-Inducing
Culture
Isolated DP thymocytes of control- and
Runx3-overexpressing TCR-Tg mice in non-
selecting MHC (TCR-Neut) were applied to
one-step RTOC, in which a sustained TCR
signal was delivered by selecting MHC-
expressing TEC (BALB/c TEC). Whereas DP
thymocytes of a control- (day 0, upper) and
Runx3-overexpressing (day 0, lower) TCR-
Neut mouse, as well as CD4−8+ cells appear-
ing in a Runx3 TCR-Neut mouse (day 0, bot-
tom left), expressed TCR at a lower level,
both types of postculture cells expressed
TCR at a higher level (day 2, upper and
lower). While control DP cells transited to
CD4SP cells in one-step RTOC, Runx3-over-
expressing DP cells did not show CD8
downregulation, though they showed in-
creased TCR expression.in a stage-specific manner and contribute to the reex- v
tpression of CD8 during the development process from
postselected DP cells to the CD8SP stage. Among the f
MRunx family proteins, Runx3 was preferentially ex-
pressed following the DP-to-CD8SP development pro- e
ecess and mainly contributed to the binding to the CD8
enhancers as well as to the CD4 silencer in CD8SP a
mcells. These results suggest that Runx proteins, particu-
larly Runx3, are involved in the development of CD8SP g
dcells through CD8 gene activation in addition to CD4 si-
lencing. G
iCurrently, several groups, including ours, have sug-
gested the involvement of Runx proteins in the genera- s
etion of CD8SP thymocytes (Ehlers et al., 2003; Taniuchi
et al., 2002a; Telfer et al., 2004; Woolf et al., 2003). We m
cpreviously showed the increase of CD8SP thymocytes
in Runx1 Tg mice (Hayashi et al., 2001; Kohu et al.,
R2005) and the decrease of CD8SP thymocytes in trans-
genic mice expressing the Runx dominant-negative t
iform (Hayashi et al., 2000). Others have focused on the
first intronic silencer region of the CD4 gene as the w
tRunx target (Ehlers et al., 2003; Taniuchi et al., 2002a).
However, silencing of CD4 may not be sufficient for T
pgenerating CD8SP cells from DP thymocytes. In fact,
previous studies reported that the CD8SP stage-spe- t
tcific CD8 enhancer does not function at the DP stage
(Ellmeier et al., 1997, 1998; Hostert et al., 1997b, 1998). p
gAmong candidates of trans-acting factors for the
CD8 gene, Ikaros may actually potentiate CD8 expres- 1
sion in DP and CD8SP thymocytes because it can acti-ate the expression of the CD8 enhancer-driven repor-
er gene in vivo; the involvement of other candidate
actors was demonstrated, but only in in vitro systems.
oreover, Ikaros was shown to bind to E8I and E8V
nhancers of the CD8 gene (Harker et al., 2002). These
nhancer loci are suggested to be involved in the alter-
tion of chromatin structure and/or nuclear compart-
entalization from the previous studies showing varie-
ated expression of CD8 in E8I- and E8II-double
eleted mice or E8V-deleted mice (Ellmeier et al., 2002;
arefalaki et al., 2002). Since Runx, as well as Ikaros,
s known to possess the ability to affect chromatin
tructure and/or nuclear compartmentalization (Telfer
t al., 2004; Zaidi et al., 2002), Runx, as well as Ikaros,
ay regulate CD8 expression through control of the
hromatin structure of the CD8 locus.
In this study, we demonstrated the strong binding of
unx to the CD8 gene enhancers E8I, E8II, and E8V in
wo CD8-bearing subpopulations, DP and CD8SP cells
n the thymus (Figure 2). Especially, Runx binding to E8I
as prominent in CD8SP cells, whereas weak binding
o E8III was observed only in DP cells (Figure 2, site c).
his finding seems consistent with the previous re-
orts; in E8I-driven reporter transgenic mice, the repor-
er gene was expressed in the CD8SP stage, but not in
he DP stage, while the reporter was specifically ex-
ressed in the DP stage in E8III-driven reporter trans-
enic mice (Ellmeier et al., 1997, 1998; Hostert et al.,
998).
Positively selected DP thymocytes show the tran-
Runx Proteins Are Involved in CD8 Reexpression
325sient downregulation of CD8 before becoming both
CD4 and CD8SP cells (Germain, 2002; Lundberg et al.,
1995; Suzuki et al., 1995). Such CD4+8lo cells in Runx
dn-TCR-Neut thymocytes did not fully reexpress CD8 in
two-step RTOC (Figure 5). As a reciprocal study, we used
a Runx3-overexpressing mouse and revealed that DP
cells transit to CD8SP cells without CD8 downregulation
even when DP cells were applied to a CD4SP-inducing
culture system (Figure 6). These results indicate that
Runx is substantially involved in CD8 reexpression at
the transition process from DP to CD8SP cells in the
thymus. Two past studies also suggested the active
function of Runx proteins for CD8 expression. In Runx3-
deficient mice, the total cell number of CD8-expressing
thymocytes and splenocytes was actually decreased,
although the authors indicated the derepression of CD4
but did not mention the impaired CD8 expression (Tani-
uchi et al., 2002a; Woolf et al., 2003). If Runx protein
affected only the CD4 silencer, DP cells selected to be
CD8SP cells would retain the DP phenotype without
CD4/8 repression. However, in the thymocytes of
Runx3 mutant mice, such as Runx3-deficient mice and
Runx dn-Tg mice, the proportion of DP cells in TCR-
highly positive cells was not particularly increased,
whereas the CD8SP cell proportion was reduced (Tani-
uchi et al., 2002a) (Figure S1).
Since the Runx dn form acts on all Runx proteins,
there may be several minor differences between Runx
dn-Tg and Runx3 KO mice. For example, the absolute
cell number of CD4SP cells in the thymus and the pe-
riphery was decreased only in Runx dn-Tg mice, but
not in Runx3 KO mice, as we have previously reported
(Hayashi et al., 2000; Taniuchi et al., 2002a; Woolf et al.,
2003). We found that CD4SP thymocytes of Runx dn-
Tg mice showed reduced cell division after they were
positively selected (unpublished data). Furthermore,
the proliferative potential and the resistance to apopto-
sis were impaired in peripheral CD4SP cells of Runx
dn-Tg mice (Hayashi et al., 2000). Since CD4SP cells
express Runx1 but barely express Runx3 (Figure 3A),
these findings suggest that Runx1 is involved in cell
proliferation and antiapoptosis in mature CD4SP cells.
On the contrary, peripheral CD8SP cells in Runx dn-
Tg mice, but not in Runx3 KO mice, showed enhanced
potentials for cell division and survival, although the
molecular basis is not known (Hayashi et al., 2000). As
another possibility, we cannot deny that the Runx dn
form does not fully inhibit Runx3 functions.
We demonstrated that Runx3 expression was ex-
tremely high in C8SP cells, while Runx1 expression was
almost the same among DP, CD4SP, and CD8SP cells
(Figure 3). Moreover, it is noteworthy that Runx3 ex-
pression initiates in postselected DP cells and af-
terwards becomes high in CD8SP but is downregulated
in the CD4SP pathway (Figure 3). Thus, it may be as-
sumed that the Runx3 upregulation closely correlates
to CD8 reactivation and CD4 silencing, resulting in lin-
eage commitment to the CD8SP lineage. This hypothe-
sis does not necessarily rule out the possibility that
other proteins, e.g., Runx1, are also involved in CD8
reactivation and CD4 silencing (Taniuchi et al., 2002a;
Woolf et al., 2003). Indeed, fetal thymocytes of Runx1-
loxP-flanked/Lck-Cre mice showed variegated expres-
sion of CD8 (Taniuchi et al., 2002a), suggesting thatCD8 expression is activated through Runx1 protein as
fetal DN thymocytes differentiate to the DP stage. How-
ever, a strong binding of Runx1 to either the CD4 si-
lencer or CD8 enhancer was not observed in normal
mouse CD8SP cells (Figure 4). Accordingly, it is as-
sumed that Runx3, but not Runx1, is one of the pre-
dominant factors for regulating CD4 and CD8 gene ex-
pression in the late stage of thymocyte development.
This assumption is supported by the findings that
Runx3 transgene induced CD4 repression, giving rise
to numerous CD8SP cells, but that Runx1 transgene
induced only a few CD8SP cells (Kohu et al., 2005; Hay-
ashi et al., 2001) (Figure S2).
Then, we propose that Runx activates CD8 enhanc-
ers as well as the CD4 silencer for reciprocal regulation
of CD4 and CD8 in mature thymocytes. As a similar
double regulator, BAF was reported to be involved in
both CD8 activation and CD4 silencing in DN and DP
thymocytes (Chi et al., 2002), although it remains un-
clear whether BAF complexes play a role in the lineage
choice of positively selected thymocytes. Considering
the selective expression of Runx3 in CD8SP lineage
cells, it is plausible that BAF complexes can function in
concert with Runx3 in the cell fate decision process.
In our two-step RTOC system, CD4+CD8lo cells ap-
pearing by transient signal can be induced to differenti-
ate either to the CD4SP stage or to the CD8SP stage
by continuing the culture with TCR ligand or by culture
without TCR ligand, respectively. This is consistent with
the hypothesis that the duration of the TCR signal can
determine the CD4/8 lineage commitment (Brugnera et
al., 2000; Singer, 2002; Yasutomo et al., 2000). This
study, to our knowledge, is the first to describe the
mechanism by which Runx proteins are involved in the
reactivation of CD8, in addition to the silencing of CD4.
In the near future, whether the duration of the TCR sig-
nal determines the Runx3 expression is to be investi-
gated.
Experimental Procedures
Mice
I-Ad-restricted, ovalbumin (OVA)323–339-specific TCR-Tg mice and
Runx dominant-negative (Runx dn)-Tg mice were previously re-
ported (Hayashi et al., 2000; Sato et al., 1994). The TCR-Tg mice
had been backcrossed with RAG-2-deficient (I-Ab) mice. Because
of the absence of selecting MHC (I-Ad), thymocytes were arrested
at the DP stage and did not differentiate further to the SP stages.
Runx dn-Tg mice and Runx3-Tg mice (Kohu et al., 2005) were
backcrossed with the TCR-Tg mice, and they were designated as
Runx dn-TCR-Tg mice and Runx3-TCR-Tg mice, respectively.
C57BL/6J mice were purchased from Japan CLEA (Tokyo, Japan).
β-2microglobulin-deficient mice and I-Ab-deficient mice were pro-
vided by the Central Institute of Experimental Animals (Kawasaki,
Japan). β-2microglobulin- and I-Ab-double deficient mice were ob-
tained by backcrossing in our laboratory. Mice were maintained
under specific pathogen-free conditions and were used at the age
of 4–10 weeks. All mouse experiments were approved by the Ani-
mal Experimentation Committee, Isehara campus (Tokai University,
Kanagawa, Japan).
Reaggregated Thymus Organ Culture
DP thymocytes isolated from control and Runx dn-TCR-Tg mice
were applied to an RTOC system as previously described (Sato
et al., 2001). Briefly, BALB/c or C57BL/6 mouse embryo thymuses
(gestation day 15.5) were incubated on the surface of Nucleopore
Track-Etch Membrane (Corning, NY) in RPMI1640 medium supple-
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326mented with 10% FCS and 1.35 mM 2-deoxyguanosine for 4–5 5
Gdays and without 2-deoxyguanosine for 1 more day. After the cul-
ture, a single-cell suspension of thymic epithelial cells (TEC) was C
Gprepared by trypsinization. Thymocytes were prepared from Tg
mice, and then DP cells were collected by Dynabeads mouse CD4 A
Cand DETACHaBEAD mouse CD4 (Dynal ASA, Oslo, Norway). Both
single-cell suspensions of thymic epithelial cells and DP thymo- A
Tcytes were mixed at an equal ratio and were centrifuged. The re-
sulting cell slurry was deposited on the surface of Nucleopore r
fTrack-Etch Membrane, cultured for 1–5 days, and processed for
analysis. For two-step RTOC, DP cells were reaggregated and cul- (
itured with BALB/c TEC for 1 day, and then thymocytes were col-
lected and applied to the second RTOC with C57BL/6 TEC for an 3
cadditional 1–4 days.
c
1Flow Cytometric Analysis
mPE-anti-mouse CD4 (RM4-5), APC-anti-mouse-CD8α (53-6.7), FITC-
Danti-mouse-TCR-β (H57-597), and PE-streptavidin were purchased
Afrom eBioScience (San Diego, CA). Biotin-anti-mouse-CD69 (H1.2F3)
Tand PerCP-Cy5.5-CD4 (RM4-5) were purchased from BD Phar-
GMingen (San Diego, CA). Multicolor flow cytometry was performed
fby FACScalibur (Becton Dickinson, Mountain View, CA). Data were
5analyzed by the FlowJo program (Tree Star, OR).
G
ACell Sorting
TCD4−8− (DN), CD4+8+ (DP), CD4+8− (CD4SP), and CD4-8+ (CD8SP)
fthymocyte subpopulations were isolated from C57BL/6J mice by
5using a Dynabeads mouse CD4/DETACHaBEAD mouse CD4 (Dynal
GASA, Oslo, Norway) system combined with an anti-mouse-CD8-
Amicrobeads/Auto-MACS system (Miltenyi Biotech GmbH, Bergisch
AGlasbach, Germany). In some experiments, isolated CD4SP and
ACD8SP cells were further sorted into TCR-β+CD69+ and TCR-
aβ+CD69− cells by using FACStar (Becton Dickinson, Mountain View,
CA). CD4+8lo thymocytes were isolated from β-2microglobulin-defi-
Rcient mice and I-Ab-deficient mice by biotin-anti-CD69 Ab and the
Canti-biotin-microbeads (Miltenyi Biotech GmbH) system and were
athereafter sorted into CD4-positive fractions by FACStar.
P
7Immunoblotting
o
Cells (5 × 105 to 5 × 106 cells) were lysed for 30 min in ice-cold
f
RIPA buffer. After centrifugation, cell lysate was subjected to SDS-
G
10% (W/V) PAGE and transferred to an Immobilon-P membrane
C
(Millipore, Bedford, MA). The membrane was incubated with antise-
rum raised against the 15 amino acid carboxyl terminus of mouse
AML1, which reacts with all Runx families (anti-pan-Runx antibody) S
(Hayashi et al., 2001), or anti-AML1/RHD, which reacts specifically
S
with Runx1 (anti-Runx1, Oncogene, San Diego, CA). Signals were
c
detected by enhanced chemiluminescence (Amersham Pharmacia
D
Biotech, Little Chalfont, UK).
Chromatin Immunoprecipitation Assay A
Chromatin of thymocyte subpopulations was fixed and immuno-
precipitated with 2 g anti-pan-Runx, anti-Runx1, acetylated his- W
tone H3, or normal rabbit Ig by using the ChIP assay kit (Upstate m
Cell Signaling Solutions, Charlottesville, VA) as recommended by D
the manufacturer. After DNA purification, the presence of selected m
DNA sequences was assessed by PCR. The primers used were as t
follows: for TCR Eβ 5#-AGAATGGCCACCTGCCATAG-3#, 5#-GGTGA s
TAGCTAGAGGCTGAG; for CD4 silencer, 5#-TGTAGGCACCCGAGG
CAAAG-3#, 5#-GTTCCAGCACAGCAGCCCCA-3#; for CD8 (a) (shown
Rin Figure 2), 5#-TGCATTTGCAGAAATGGATAC-3#, 5#-ACTTCAGA
RTTTTCCTCC-3#; for CD8 (b), 5#-CTAGCTGAACCTGGTGCACA-3#,
A5#-ATGCAGGGAGGAGAGAGAAG-3#; for CD8 (c), 5#-GACAGTATC
PTCAAAGGCTAG-3#, 5#-ATGCTCTAAGACAGAAGGTTG-3#; for CD8
(d), 5#CGCATTCAGCTCCAACTAGG-3#, 5#-GAGTCTTGCATCTTACA
RCTG; for CD8 (e), 5#GTAGATAGATGAGACAGACAG-3#, 5#-ACACTGCA
TCTTACCAACCAG-3#; for CD8 (f), 5#-ACCCTCAGGTCCTGAAG
AGTA-3#, 5#-GTGCAGTTGAGTAGAAGCCA-3#; for CD8 (g), 5#-TAG
gACTCAAGGGAGAAGAGA-3#, 5#-TCCCTGGCTGGAGGTACCTG-3#;
rfor CD8 (h), 5#-GCCTCTGCTACTTCTAGATG-3#, 5#-CTCAGATGC
CGATCTCATTT-3#; for CD8 (i), 5#-CACTTCCTTTTCTCCCAACC-3#, B
y5#-ATGAAGCTTGTGAATGGACC-3#; for CD8 (j), 5#-CTCTCTACTC
GATCTTTCCC-3#, 5#-GAGAAGCTGTGCACTTCGTT-3#; for CD8 (k), n#-AGCCCCTGATCTTTCCCTAT-3#, 5#-TCCGTCAGAGCCGAGCT
TG-3#; for CD8 (l), 5#-GAGTGGTTCATATCACCTAG-3#, 5#-GCTGA
TCACAACCATCTGT-3#; for CD8 (m), 5#-GAAGCTAACACAGTG
AAGGT-3#, 5#-GAAGATACTGTTTCAGCAACT-3#; for CD8 (n), 5#-
CACAGAGAAACCCTGCCTTG-3#, 5#-TGCCTGCCCATCACTATA
TT-3#; for CD8 (o), 5#-CTGCACCCAAGATTCACCCG-3#, 5#-ACT
GCCCTTGGATAGGTGC-3#; and for CD8 (p), 5#-AGTGGAGAAGC
AAGCCACA-3#, 5#-ATTCGTGTCCCTCATGGCAG-3#. PCR was car-
ied out for 1 min at 94°C, 1 min at 59°C, and 1 min at 72°C, except
or annealing temperature of CD4 silencer (64°C), CD8 (b), (54°C),
c) (61°C), (d) (61°C), and (e) (53°C). The numbers of PCR cycles for
mmunoprecipitants of anti-pan-Runx and anti-Ac-H3 were 32, 34,
6, and 38, except for the case of CD4 silencer (30, 32, 34, and 36
ycles). For anti-Runx1 immunoprecipitants, the numbers of PCR
ycles were 36, 38, 40, and 42. PCR products were resolved in a
.8% agarose gel and were transferred onto nylon membranes. The
embranes were incubated with 32P-labeled DNA oligomers. The
NA oligomers for hybridization were as follows: for TCR Eβ 5#-
GGGTTTGAAGACAGGATGT-3#; for CD4 silencer, 5#-ATACGAAGC
AGGCAACAGA-3#; for CD8 (a), 5#-AGAACAGAGCTGAGAGCATAA
TGA-3#; for CD8 (b), 5#-TGCCTGTAATCCCAGTACTTGGGAG-3#;
or CD8 (c), 5#-TAGTCCCTCAGATCAGCTCAGGTCT-3#; for CD8 (d),
#-CTGCCTGTCTGTCCATCTGTCTGCT-3#; for CD8 (e), 5#-GGCAA
ATTGCCAGGATAGACAGAT-3#; for CD8 (f), ATACCTCCAGTGATG
GGAAGTCAC-3#; for CD8 (g), 5#-GCACCAGACCATGCTTTTAGG
CCA-3#; for CD8 (h), 5#-GAGGTTACAGCAGGCCACAGCATGT-3#;
or CD8 (i), 5#-CCTGACTTAACCTATGAGTGGGATG-3#; for CD8 (j),
#-AATCAGCACAGAATCAGCCAGCTGC-3#; for CD8 (k), 5#-CCAT
TGTGGTTCCAGACTTCAGGA-3#; for CD8 (l), 5#-CCAGAAGAGG
CATCAGATTCCTAG-3#; for CD8 (m), 5#-GACTCACAATGAGTCAA
GTACAGA-3#; for, CD8 (n), 5#-CCATGACCAAGGGTACTTATAG
AG-3#; for CD8 (o), 5#-AGAGAGCAGCAAGACCTTAGAAACG-3#;
nd for CD8 (p), 5#-TCTTCCAGAACTCCAGCTCCAAACT-3#.
T-PCR
ells of pre- and postculture of the two-step RTOC were collected,
nd poly(A)+ RNAs were isolated from them. After cDNA synthesis,
CR was carried out for 1 min at 94°C, 1 min at 59°C, and 1 min at
2°C. The numbers of PCR cycles were 40, 38, 36, and 34 (perforin),
r 28, 26, 24, and 22 (GAPDH). The primers used were as follows:
or perforin, 5#-TGAGAAGACCTATCAGGACC-3#, 5#-ATAGGAGGA
ATGAGCCTGT-3#; for GAPDH, 5#-AATTCAACGGCACAGTCAAGG
CGAGAATG-3#, 5#-GCGGCACGTCAGATCCACGACGGAC-3#.
upplemental Data
upplemental Data including two figures are available with this arti-
le online at http://www.immunity.com/cgi/content/full/22/3/317/
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